Pharmaceutical company Eli Lilly issued a warning in an open letter on Thursday about the dangers of fake and compounded versions of its diabetes and weight loss medications Mounjaro and Zepbound.
Eli Lilly's main competitor, Novo Nordisk, which sells Ozempic and Wegovy, has also filed lawsuits against med spas purportedly selling knockoff versions. In its Thursday open letter, Eli Lilly issued a major warning to consumers, saying the company is "deeply" concerned about the proliferation of online sales of fake versions of its products, and that people should never put products labeled "research purposes only" or "not for human consumption" into their bodies.Fake drugs aside, Eli Lilly is also raising concerns about compounding pharmacies.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ABC - 🏆 471. / 51 Read more »
Source: 6abc - 🏆 250. / 63 Read more »